Cargando…

Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer

The onset and selection of resistant clones during cancer treatment with chemotherapy or targeted therapy is a major issue in the clinical management of metastatic colorectal cancer patients. It is possible that a more personalized treatment selection, using reliable response-to-therapy predictive b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garajová, Ingrid, Ferracin, Manuela, Porcellini, Elisa, Palloni, Andrea, Abbati, Francesca, Biasco, Guido, Brandi, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536035/ https://www.ncbi.nlm.nih.gov/pubmed/28714940 http://dx.doi.org/10.3390/ijms18071547

Ejemplares similares

Interplay between small and long non‐coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces
por: Riefolo, Mattia, et al.
Publicado: (2018)

Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases
por: Brandi, Giovanni, et al.
Publicado: (2018)

MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma—a step towards personalized therapy
por: Garajová, Ingrid, et al.
Publicado: (2015)

c-Met as a Target for Personalized Therapy
por: Garajová, Ingrid, et al.
Publicado: (2015)

Neoadjuvant Treatment in Rectal Cancer: Actual Status
por: Garajová, Ingrid, et al.
Publicado: (2011)

Adjuvant treatment in biliary tract cancer
por: Palloni, Andrea, et al.
Publicado: (2019)

Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept
por: De Lorenzo, Stefania, et al.
Publicado: (2018)

Are Non-Coding RNAs Useful Biomarkers in Parathyroid Tumorigenesis?
por: Aurilia, Cinzia, et al.
Publicado: (2021)

Cancer Site-Specific Multiple microRNA Quantification by Droplet Digital PCR
por: Laprovitera, Noemi, et al.
Publicado: (2018)

Early Onset Metastatic Colorectal Cancer: Current Insights and Clinical Management of a Rising Condition
por: Medici, Bianca, et al.
Publicado: (2023)

In Reply
por: Brandi, Giovanni, et al.
Publicado: (2016)

Current and New Predictors for Treatment Response in Metastatic Colorectal Cancer. The Role of Circulating miRNAs as Biomarkers
por: Gherman, Alexandra, et al.
Publicado: (2020)

Improvements in Systemic Therapies for Advanced Malignant Mesothelioma
por: Deiana, Chiara, et al.
Publicado: (2023)

The Involvement of Long Non-Coding RNAs in Bone
por: Aurilia, Cinzia, et al.
Publicado: (2021)

Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies
por: Brandi, Giovanni, et al.
Publicado: (2015)

Long Non-Coding RNAs As Potential Novel Prognostic Biomarkers in Colorectal Cancer
por: Saus, Ester, et al.
Publicado: (2016)

Curcumin Targeting Non-Coding RNAs in Colorectal Cancer: Therapeutic and Biomarker Implications
por: Li, Jiaying, et al.
Publicado: (2022)

Non-Coding RNAs as Biomarkers of Tumor Progression and Metastatic Spread in Epithelial Ovarian Cancer
por: Seborova, Karolina, et al.
Publicado: (2021)

MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary
por: Laprovitera, Noemi, et al.
Publicado: (2021)

Current role of non-coding RNAs in the clinical setting
por: Vicentini, Caterina, et al.
Publicado: (2019)

Current Diagnostic Methods and Non-Coding RNAs as Possible Biomarkers in Huntington’s Disease
por: Pellegrini, Miguel, et al.
Publicado: (2022)

Serum coding and non‐coding RNAs as biomarkers of NAFLD and fibrosis severity
por: Di Mauro, Stefania, et al.
Publicado: (2019)

Circulating Coding and Long Non-Coding RNAs as Potential Biomarkers of Idiopathic Pulmonary Fibrosis
por: Di Mauro, Stefania, et al.
Publicado: (2020)

Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?
por: Rizzo, Alessandro, et al.
Publicado: (2021)

Molecular Mechanisms Underlying the Role of MicroRNAs in the Chemoresistance of Pancreatic Cancer
por: Garajová, Ingrid, et al.
Publicado: (2014)

Focus on Therapeutic Options for Surgically Resectable Pancreatic Adenocarcinoma Based on Novel Biomarkers
por: Olivari, Alessandro, et al.
Publicado: (2023)

Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs
por: Lulli, Matteo, et al.
Publicado: (2022)

Is post‐transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases?
por: Brandi, Giovanni, et al.
Publicado: (2020)

Current Status of Long Non-Coding RNAs in Human Cancer with Specific Focus on Colorectal Cancer
por: Smolle, Maria, et al.
Publicado: (2014)

Biomarkers (mRNAs and Non-Coding RNAs) for the Diagnosis and Prognosis of Colorectal Cancer – From the Body Fluid to Tissue Level
por: He, Jinhua, et al.
Publicado: (2021)

Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment
por: Palcau, Alina Catalina, et al.
Publicado: (2023)

Coding and Non-Coding RNAs, as Male Fertility and Infertility Biomarkers
por: Aliakbari, Fereshteh, et al.
Publicado: (2021)

Long non-coding RNAs in colorectal cancer
por: Xie, Xia, et al.
Publicado: (2015)

Non-coding RNAs as Putative Biomarkers of Cancer-Associated Cachexia
por: Donzelli, Sara, et al.
Publicado: (2020)

KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC
por: Cinausero, Marika, et al.
Publicado: (2019)

Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities
por: Porru, Manuela, et al.
Publicado: (2018)

Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer
por: Grassi, Elisa, et al.
Publicado: (2021)

Non-coding RNAs as potential biomarkers in osteosarcoma
por: Fan, Lijuan, et al.
Publicado: (2022)

MicroRNAs as Potential Biomarkers in Pituitary Adenomas
por: Donati, Simone, et al.
Publicado: (2021)

Circulating non-coding RNAs in recurrent and metastatic ovarian cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p2b4he7ar6hbd9murk8vk5m97q